BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 21130491)

  • 41. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation.
    Garcia A; Bussaglia E; Machin P; Matias-Guiu X; Prat J
    Int J Gynecol Pathol; 2000 Apr; 19(2):152-7. PubMed ID: 10782412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
    Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
    J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types.
    Okada S; Tsuda H; Takarabe T; Yoshikawa H; Taketani Y; Hirohashi S
    Jpn J Cancer Res; 2002 Jul; 93(7):798-806. PubMed ID: 12149146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.
    Matsumoto T; Yamazaki M; Takahashi H; Kajita S; Suzuki E; Tsuruta T; Saegusa M
    Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
    Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
    Ren F; Wang DB; Li T
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ARID1A mutations in endometriosis-associated ovarian carcinomas.
    Wiegand KC; Shah SP; Al-Agha OM; Zhao Y; Tse K; Zeng T; Senz J; McConechy MK; Anglesio MS; Kalloger SE; Yang W; Heravi-Moussavi A; Giuliany R; Chow C; Fee J; Zayed A; Prentice L; Melnyk N; Turashvili G; Delaney AD; Madore J; Yip S; McPherson AW; Ha G; Bell L; Fereday S; Tam A; Galletta L; Tonin PN; Provencher D; Miller D; Jones SJ; Moore RA; Morin GB; Oloumi A; Boyd N; Aparicio SA; Shih IeM; Mes-Masson AM; Bowtell DD; Hirst M; Gilks B; Marra MA; Huntsman DG
    N Engl J Med; 2010 Oct; 363(16):1532-43. PubMed ID: 20942669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.
    Jiang X; Morland SJ; Hitchcock A; Thomas EJ; Campbell IG
    Cancer Res; 1998 Apr; 58(8):1707-12. PubMed ID: 9563487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway.
    Yamamoto S; Tsuda H; Takano M; Hase K; Tamai S; Matsubara O
    J Pathol; 2008 Sep; 216(1):103-10. PubMed ID: 18600856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas.
    Plisiecka-Hałasa J; Dansonka-Mieszkowska A; Kraszewska E; Dańska-Bidzińska A; Kupryjańczyk J
    Anticancer Res; 2008; 28(2A):989-96. PubMed ID: 18507046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Endometriosis-related ovarian tumors].
    Schmidt D; Ulrich U
    Pathologe; 2014 Jul; 35(4):348-54. PubMed ID: 24992974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endometriosis and the neoplastic process.
    Varma R; Rollason T; Gupta JK; Maher ER
    Reproduction; 2004 Mar; 127(3):293-304. PubMed ID: 15016949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
    Kobayashi H; Kajiwara H; Kanayama S; Yamada Y; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
    Oncol Rep; 2009 Aug; 22(2):233-40. PubMed ID: 19578761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer].
    Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.
    Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK
    Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N; Jaafart H; Isa MN; Abdullah JM
    Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
    Werness BA; Parvatiyar P; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Wiest J; Tsukada Y; Ponder BA; Piver MS
    J Natl Cancer Inst; 2000 Jul; 92(13):1088-91. PubMed ID: 10880552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.